| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |